Existing concepts and templates created by the regulator and professional bodies are also highlighted, such as the FCA’s ...
The report summarises that ‘firms should not have to overhaul the way they work, but complying with new expectations may mean ...
Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus ...
GlobalData on MSN5d
Hutchmed concludes enrolment in Phase II trial of fanregratinib for IHCCHutchmed has concluded enrolment of its multi-centre Phase II trial of fanregratinib (HMPL-453), a treatment for intrahepatic ...
Q4 2024 Earnings Call Transcript March 7, 2025 Oncolytics Biotech Inc. beats earnings expectations. Reported EPS is $-0.06949, expectations were $-0.08. Operator: Good morning, and welcome to ...
BRACELET-1 results in HR+/HER2- metastatic breast cancer surpass expectations, providing meaningful data for a registration-enabling study Data from GOBLET in pancreatic ...
Q4 2024 Earnings Call Transcript March 6, 2025 Delcath Systems, Inc. beats earnings expectations. Reported EPS is $0.05, ...
Spring is in the air. Birds are singing, flowers are blooming and the IRS is calling. I may be a little ahead of the ...
Sandra Pennell; Senior Vice President - Finance, Chief Accounting Officer, Executive Officer; Delcath Systems Inc Thank you and once again, welcome to Delcath Systems fourth quarter in full year 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback